- Home
- ATXS vs EGY Comparison
ATXS vs EGY Comparison
Compare ATXS & EGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXS
- EGY
- Stock Information
- Founded
- ATXS 2008
- EGY 1985
- Country
- ATXS United States
- EGY United States
- Employees
- ATXS N/A
- EGY N/A
- Industry
- ATXS Biotechnology: Pharmaceutical Preparations
- EGY Oil & Gas Production
- Sector
- ATXS Health Care
- EGY Energy
- Exchange
- ATXS Nasdaq
- EGY Nasdaq
- Market Cap
- ATXS 584.1M
- EGY 497.4M
- IPO Year
- ATXS 2015
- EGY N/A
- Fundamental
- Price
- ATXS $9.55
- EGY $4.73
- Analyst Decision
- ATXS Strong Buy
- EGY Strong Buy
- Analyst Count
- ATXS 5
- EGY 1
- Target Price
- ATXS $28.00
- EGY $8.00
- AVG Volume (30 Days)
- ATXS 340.4K
- EGY 1.0M
- Earning Date
- ATXS 11-13-2024
- EGY 11-11-2024
- Dividend Yield
- ATXS N/A
- EGY 5.31%
- EPS Growth
- ATXS N/A
- EGY 170.05
- EPS
- ATXS N/A
- EGY 0.86
- Revenue
- ATXS N/A
- EGY $506,421,000.00
- Revenue This Year
- ATXS N/A
- EGY $0.48
- Revenue Next Year
- ATXS N/A
- EGY N/A
- P/E Ratio
- ATXS N/A
- EGY $5.48
- Revenue Growth
- ATXS N/A
- EGY 25.82
- 52 Week Low
- ATXS $5.88
- EGY $4.03
- 52 Week High
- ATXS $16.90
- EGY $7.51
- Technical
- Relative Strength Index (RSI)
- ATXS 41.21
- EGY 32.96
- Support Level
- ATXS $9.40
- EGY $4.74
- Resistance Level
- ATXS $9.99
- EGY $5.08
- Average True Range (ATR)
- ATXS 0.58
- EGY 0.18
- MACD
- ATXS -0.01
- EGY -0.00
- Stochastic Oscillator
- ATXS 9.32
- EGY 21.91
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.
About EGY VAALCO Energy Inc.
VAALCO Energy Inc is an independent energy company operating in the United States. It is principally engaged in the acquisition, exploration, development, and production of crude oil and natural gas. The company operates through geographical segments namely Gabon, Egypt, Canada, Equatorial Guinea and Corporate and Other. The company generates maximum revenue from the Gabon segment.